As Freenome’s Chief Medical Officer, Girish Putcha oversees the clinical validation of Freenome’s blood tests and helps navigate the regulatory and financial complexities of the healthcare industry. As director of laboratory science for Palmetto GBA’s MolDX program, Girish continues to oversee coverage and reimbursement for molecular testing for approximately half of the Medicare population.
Mr. Putcha has held senior leadership roles, including founding laboratory director and Chief Medical Officer, at Ariosa Diagnostics, Crescendo Bioscience, Life Technologies, and VitaPath Genetics. His entrepreneurial experience at Panorama Capital and RiverVest Venture Partners included investments in biopharmaceuticals, medical devices, and diagnostics and services. He served on the boards of portfolio companies, Presidio Pharmaceuticals, PowerVision, and Phenomix.
Girish holds an MD in molecular neuroscience from Washington University in St. Louis, and completed his fellowship in molecular genetic pathology at Stanford University.
Exploiting AI: From Discovery to Treatment
11:10 AM - 12:00 PM